-+ 0.00%
-+ 0.00%
-+ 0.00%

Rigel Pharmaceuticals Affirms FY2026 Sales Guidance of $275.000M-$290.000M

Benzinga·03/03/2026 22:04:03
Listen to the news
Rigel Pharmaceuticals (NASDAQ:RIGL) affirms FY2026 sales outlook from $275.000 million-$290.000 million to $275.000 million-$290.000 million.